ACADEMIC PUBLICATION SERIES

VIEN GUT MODEL

Integrated Outpatient Care for Complex Multimorbid Chronic Diseases [1]

Part A — Foundations of the Vien Gut Model Academic Series [1]

DOCUMENT A.1 EBM REFERENCE FRAMEWORK: WHAT + HOW + DATA-TO-OPERATE [1]

From gaps to an operable structure [1]

Vien Gut Model — First Systematic Collection of Academic Documents — March 2026 [1]
Ho Chi Minh City, Vietnam [1]

EXECUTIVE SUMMARY FOR EXPERT REVIEWERS [4]

DOCUMENT A.1 — EBM REFERENCE FRAMEWORK: WHAT + HOW + DATA-TO-OPERATE [4]
*From gaps to an operable structure* [4]

Nguyễn Đình Quang — Vien Gut Model [4]
March 2026 — Ho Chi Minh City, Vietnam [4]

1. Context and Central Question

Document A.1 stems from a practical observation: well-trained doctors, despite having full international guidelines, still face difficulties when treating complex chronic multimorbid patients. [4] The cause does not lie in the quality of the guidelines, but in the fact that guidelines are only one of three layers needed to operate integrated care. [4] The remaining two layers — HOW and DATA-to-operate — do not exist in the current EBM chain as systematically designed components. [4]

“Guidelines state WHAT needs to be achieved, but do not state HOW when multiple guidelines conflict on the same patient, and do not provide longitudinal DATA to trigger decisions (DATA-to-operate).” [5]

2. The EBM Chain and Structural Breakpoints

The document analyzes the EBM chain through 8 steps — from basic research to guideline development — and points out that the first 7 steps perform excellently for single diseases, but the 8th step (clinical application) is the breakpoint when the subject is a complex chronic multimorbid patient. [5]

Cause [6] Description [6]
Single-disease guidelines RCTs exclude severe multimorbid patients — evidence is generated on “clean” populations
No integration mechanism No guideline describes how to coordinate when a drug good for one axis harms another
No coordinator EBM chain ends at “the doctor applying the guideline” — no one is identified as having overall responsibility
No longitudinal data Chronic multimorbidity requires time-series data — guidelines rely only on cross-sectional views

2.1. EBM Feedback Loops — and Structural Limits

The EBM chain has a self-improving feedback loop: discovering limitations → new research → updated guidelines. [6] This loop performs excellently for WHAT (guidelines get better), but does not create HOW. [6] Structural reason: HOW is not a product of RCTs or basic research — HOW is a product of structured integrated clinical practice over a long period. [6] The EBM chain was not designed to create this layer. [6]

3. The Three-Layer Framework: WHAT – HOW – DATA-to-operate

Mô hình Viện Gút does not replace EBM — it completes EBM by adding the two missing layers. [7] These three layers are inseparable — they form a single integrated framework: [7]

Layer [7, 8] Content [7, 8]
WHAT Guidelines and evidence — already exist, need to be reorganized into a clinical priority map for each specific multimorbid patient. The challenge is not a lack of guidelines but organizing multiple single-disease guidelines into a unified plan.
HOW Structured clinical operations — the missing layer in EBM. Specifically describes: who does what, when, based on what threshold, response SLA duration, and when to activate safety valves. Developed by Viện Gút over 18 years of practice.
DATA-to-operate Longitudinal data triggering decisions — not research data but clinical data collected in a structured way, connecting WHAT to HOW in real-time.

3.1. Three Layers Cannot Operate Individually

Missing Layer? [8, 9] Consequence [8, 9] Clinical Illustration [8, 9]
Missing HOW WHAT stays on paper, not translated into integrated action Gout + CKD G4 + heart failure: 3 conflicting guidelines, no coordinator
Missing DATA-to-operate HOW operates blindly, decisions based on single snapshots Failure to see eGFR sliding down → late activation of safety valve
Missing WHAT HOW + DATA operate without standards Does not happen in Mô hình VG — WHAT is always kept from guidelines

4. Links to the Four Verification Targets (Part C)

The WHAT–HOW–DATA-to-operate framework is the operational foundation for all four verification targets — none can be achieved with WHAT alone: [9]

Target [9, 10] WHAT (Guideline) [9, 10] HOW (Operations) [9, 10] DATA-to-operate [9, 10]
C.1 Crystal-free T2T urate lowering (ACR/EULAR) Phasing, safe renal-hepatic polypharmacy management Longitudinal US caliper mm² monitoring of urate crystals
C.2 Kidney Preservation KDIGO 2024 CKD management Resolving conflicts between urate-lowering drugs and kidney function Time-series eGFR, creatinine, albuminuria
C.3 Reduced Heart Decompensation ESC 2021 heart failure Balancing diuretics–urate lowering–kidney protection BNP/NT-proBNP, EF, emergency hospitalization frequency
C.4 Liver Cirrhosis Re-compensation EASL 2018 decompensated cirrhosis Polypharmacy management to avoid hepatotoxicity, coagulation monitoring Child–Pugh, MELD, Fibroscan, time-series albumin

5. Position in the Documentation System

A.1 is the central theoretical framework of Part A. [10] It lays the foundation for the entire document series by pointing out the structural breakpoint in the EBM chain and presenting the three-layer framework as a solution. [10] Position: A.0 (architectural statement) → A.1 (EBM framework — this document) → A.2 (definition of the three layers) → A.3 (gap evidence) → A.4–A.5 (terminology). [10] Part B implements HOW + DATA-to-operate into operational procedures. Part C verifies results on target organs. [10]

6. Conclusion

The EBM chain is a great achievement of modern medicine — but it was designed according to single-disease logic. [11] When the subject is a complex chronic multimorbid patient (4–7 severe diseases simultaneously, multiple pathological spirals, multiple guideline conflicts), the EBM chain encounters a structural breakpoint at the application step. [11] The WHAT–HOW–DATA-to-operate framework of the Mô hình Viện Gút is the result of systematization from 18 years of integrated clinical practice — filling the structural gaps that the EBM chain was not designed to create. [11]

*Vien Gut Model does not replace EBM — it completes EBM by adding the two missing layers (HOW and DATA-to-operate) and verifying outcomes on four target organs.* [11]

REFERENCES (abridged) [12, 13]

[1] Sackett DL, et al. BMJ. 1996;312(7023):71–72.
[2] Barnett K, et al. Lancet. 2012;380(9836):37–43.
[3] Wagner EH, et al. Health Aff. 2001;20(6):64–78.
[6] Tinetti ME, et al. N Engl J Med. 2004;351(27):2870–2874.
[8] WHO. Framework on Integrated, People-centred Health Services. Geneva: WHO; 2016.
[10] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 ACR Guideline for Gout.
[11] KDIGO. 2024 Clinical Practice Guideline for CKD.
[12] McDonagh TA, et al. 2021 ESC Guidelines for heart failure.
[13] EASL. Clinical Practice Guidelines for decompensated cirrhosis. J Hepatol. 2018.

*Note: Full list (13 documents): see full text of A.1.* [13]

*Viện Gút is ready to share the entire model with the international medical community as a public asset, serving the goal of improving care for complex chronic multimorbid patients in 129 low- and middle-income countries.* [13]

ACADEMIC PUBLICATION SERIES

VIEN GUT MODEL

Integrated Outpatient Care for Complex Multimorbid Chronic Diseases [1]

Part A — Foundations of the Vien Gut Model Academic Series [1]

DOCUMENT A.1 EBM REFERENCE FRAMEWORK: WHAT + HOW + DATA-TO-OPERATE [1]

From gaps to an operable structure [1]

Vien Gut Model — First Systematic Collection of Academic Documents — March 2026 [1]
Ho Chi Minh City, Vietnam [1]

EXECUTIVE SUMMARY FOR EXPERT REVIEWERS [4]

DOCUMENT A.1 — EBM REFERENCE FRAMEWORK: WHAT + HOW + DATA-TO-OPERATE [4]
*From gaps to an operable structure* [4]

Nguyễn Đình Quang — Vien Gut Model [4]
March 2026 — Ho Chi Minh City, Vietnam [4]

1. Context and Central Question

Document A.1 stems from a practical observation: well-trained doctors, despite having full international guidelines, still face difficulties when treating complex chronic multimorbid patients. [4] The cause does not lie in the quality of the guidelines, but in the fact that guidelines are only one of three layers needed to operate integrated care. [4] The remaining two layers — HOW and DATA-to-operate — do not exist in the current EBM chain as systematically designed components. [4]

“Guidelines state WHAT needs to be achieved, but do not state HOW when multiple guidelines conflict on the same patient, and do not provide longitudinal DATA to trigger decisions (DATA-to-operate).” [5]

2. The EBM Chain and Structural Breakpoints

The document analyzes the EBM chain through 8 steps — from basic research to guideline development — and points out that the first 7 steps perform excellently for single diseases, but the 8th step (clinical application) is the breakpoint when the subject is a complex chronic multimorbid patient. [5]

Cause [6] Description [6]
Single-disease guidelines RCTs exclude severe multimorbid patients — evidence is generated on “clean” populations
No integration mechanism No guideline describes how to coordinate when a drug good for one axis harms another
No coordinator EBM chain ends at “the doctor applying the guideline” — no one is identified as having overall responsibility
No longitudinal data Chronic multimorbidity requires time-series data — guidelines rely only on cross-sectional views

2.1. EBM Feedback Loops — and Structural Limits

The EBM chain has a self-improving feedback loop: discovering limitations → new research → updated guidelines. [6] This loop performs excellently for WHAT (guidelines get better), but does not create HOW. [6] Structural reason: HOW is not a product of RCTs or basic research — HOW is a product of structured integrated clinical practice over a long period. [6] The EBM chain was not designed to create this layer. [6]

3. The Three-Layer Framework: WHAT – HOW – DATA-to-operate

Mô hình Viện Gút does not replace EBM — it completes EBM by adding the two missing layers. [7] These three layers are inseparable — they form a single integrated framework: [7]

Layer [7, 8] Content [7, 8]
WHAT Guidelines and evidence — already exist, need to be reorganized into a clinical priority map for each specific multimorbid patient. The challenge is not a lack of guidelines but organizing multiple single-disease guidelines into a unified plan.
HOW Structured clinical operations — the missing layer in EBM. Specifically describes: who does what, when, based on what threshold, response SLA duration, and when to activate safety valves. Developed by Viện Gút over 18 years of practice.
DATA-to-operate Longitudinal data triggering decisions — not research data but clinical data collected in a structured way, connecting WHAT to HOW in real-time.

3.1. Three Layers Cannot Operate Individually

Missing Layer? [8, 9] Consequence [8, 9] Clinical Illustration [8, 9]
Missing HOW WHAT stays on paper, not translated into integrated action Gout + CKD G4 + heart failure: 3 conflicting guidelines, no coordinator
Missing DATA-to-operate HOW operates blindly, decisions based on single snapshots Failure to see eGFR sliding down → late activation of safety valve
Missing WHAT HOW + DATA operate without standards Does not happen in Mô hình VG — WHAT is always kept from guidelines

4. Links to the Four Verification Targets (Part C)

The WHAT–HOW–DATA-to-operate framework is the operational foundation for all four verification targets — none can be achieved with WHAT alone: [9]

Target [9, 10] WHAT (Guideline) [9, 10] HOW (Operations) [9, 10] DATA-to-operate [9, 10]
C.1 Crystal-free T2T urate lowering (ACR/EULAR) Phasing, safe renal-hepatic polypharmacy management Longitudinal US caliper mm² monitoring of urate crystals
C.2 Kidney Preservation KDIGO 2024 CKD management Resolving conflicts between urate-lowering drugs and kidney function Time-series eGFR, creatinine, albuminuria
C.3 Reduced Heart Decompensation ESC 2021 heart failure Balancing diuretics–urate lowering–kidney protection BNP/NT-proBNP, EF, emergency hospitalization frequency
C.4 Liver Cirrhosis Re-compensation EASL 2018 decompensated cirrhosis Polypharmacy management to avoid hepatotoxicity, coagulation monitoring Child–Pugh, MELD, Fibroscan, time-series albumin

5. Position in the Documentation System

A.1 is the central theoretical framework of Part A. [10] It lays the foundation for the entire document series by pointing out the structural breakpoint in the EBM chain and presenting the three-layer framework as a solution. [10] Position: A.0 (architectural statement) → A.1 (EBM framework — this document) → A.2 (definition of the three layers) → A.3 (gap evidence) → A.4–A.5 (terminology). [10] Part B implements HOW + DATA-to-operate into operational procedures. Part C verifies results on target organs. [10]

6. Conclusion

The EBM chain is a great achievement of modern medicine — but it was designed according to single-disease logic. [11] When the subject is a complex chronic multimorbid patient (4–7 severe diseases simultaneously, multiple pathological spirals, multiple guideline conflicts), the EBM chain encounters a structural breakpoint at the application step. [11] The WHAT–HOW–DATA-to-operate framework of the Mô hình Viện Gút is the result of systematization from 18 years of integrated clinical practice — filling the structural gaps that the EBM chain was not designed to create. [11]

*Vien Gut Model does not replace EBM — it completes EBM by adding the two missing layers (HOW and DATA-to-operate) and verifying outcomes on four target organs.* [11]

REFERENCES (abridged) [12, 13]

[1] Sackett DL, et al. BMJ. 1996;312(7023):71–72.
[2] Barnett K, et al. Lancet. 2012;380(9836):37–43.
[3] Wagner EH, et al. Health Aff. 2001;20(6):64–78.
[6] Tinetti ME, et al. N Engl J Med. 2004;351(27):2870–2874.
[8] WHO. Framework on Integrated, People-centred Health Services. Geneva: WHO; 2016.
[10] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 ACR Guideline for Gout.
[11] KDIGO. 2024 Clinical Practice Guideline for CKD.
[12] McDonagh TA, et al. 2021 ESC Guidelines for heart failure.
[13] EASL. Clinical Practice Guidelines for decompensated cirrhosis. J Hepatol. 2018.

*Note: Full list (13 documents): see full text of A.1.* [13]

*Viện Gút is ready to share the entire model with the international medical community as a public asset, serving the goal of improving care for complex chronic multimorbid patients in 129 low- and middle-income countries.* [13]